Life Science Webinars
-
The Importance Of Cell Media Analysis In Upstream Bioprocess Development
10/13/2021
Experts from industry and academia to explore current trends in upstream bioprocessing and the impact of real-time cell media analysis on process improvements and process analytical technologies.
-
Application Of Two-Dimensional Chromatography To Improve Productivity Of Analytical Testing Of Cell & Gene Therapy Products
10/13/2021
Analytical characterization of cell and gene therapy products remains a challenging, costly, and time-consuming task. In this video we present a proof-of-concept work demonstrating application of multidimensional chromatography for characterization of Adenovirus type 5 (Ad5)-based product that not only allowed increased productivity, but also limits the sample volume needed for the analysis.
-
Unveiling The Potential Of Your AAV Gene Therapy: Orthogonal Methods To Understand And Define CQAs
10/13/2021
As with all biopharmaceuticals, it is important to identify and monitor the critical quality attributes (CQAs) of these products to ensure their safety and efficacy. Our experts present a range of orthogonal methods to understand and define the CQAs of AAV products.
-
Production Of Therapeutic Proteins In CHO Cells
10/12/2021
Despite the widespread use of CHO cells in therapeutic protein production, the presence of many CHO cell line options and the need to optimize cell culture conditions for every cell line in a product-specific manner can lead to extended timelines and substantial cost in the development of a cell line for a new biologic.
-
Optimizing Cell & Gene Therapy Manufacturing Post-COVID
10/8/2021
Cell and gene therapy developers have felt the pressure to optimize processes and streamline activities in order to ensure clinical and commercial success of these critical therapies.
-
Better Bioprocessing Efficiency Through Centralized Orchestration
10/7/2021
Learn how orchestration software improves bioprocessing efficiency through the centralized configuration and management of connected unit operations for process and workflow automation across the plant floor.
-
Reduce Protein Biologic Development Risk
10/6/2021
Potency assays are an important part of the drug development process and are required throughout the lifetime of the product. Explore the process of assay development, qualification, and validation for critical potency assays and how Sartorius supports customers through this vital step.
-
Increase Upstream Bioprocessing Efficiency With Process Analytics
10/1/2021
The upstream bioprocess contributes significantly to product quality and manufacturing efficiency. This webcast presents strategies for inline process analytics aimed at automated feed control.
-
Recombinant Antibody Technology: Versatile Platforms For Diverse Engineering And Custom Services
9/22/2021
Antibodies play a critical role in research, diagnostics and therapeutics. Recombinant antibodies offer a wide range of quality attributes, with one key advantage being their amenability to sequence-based editing to meet specific research goals. Learn about the latest developments in recombinant antibody technology including a platform where recombinant antibodies can be rapidly engineered into diverse formats and novel molecules such as immunocytokines or bispecific antibodies.
-
Cell Line Development Toolbox For Intensified Bioprocessing
9/8/2021
If intensified processes lead to productivity improvements, then the Cell Line Development Toolbox holds the answers to make intensified bioprocessing a reality. Learn more about these technologies to optimize clone selection, shorten seed trains, and speed up early process development.